Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Randomized Controlled Pilot Study
Sponsor: Nanfang Hospital, Southern Medical University
Summary
The study was a single-center, randomized controlled pilot study. To explore the cardioprotective effect of cardiopeptidin on non-heart disease patients with severe cardiac injury by comparing whether cardiopeptidin was used.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
234
Start Date
2023-02-27
Completion Date
2023-11-25
Last Updated
2026-09-17
Healthy Volunteers
No
Conditions
Interventions
Cardiopeptidin
Cardiopeptidin was administered intravenously once a day with cardiopeptidin for 3 days.The dosing regimen follows the recommended dosage of 1 mg/kg/day as outlined in the product manual, with doses calculated based on the ideal body weight.
50 ml of normal saline intravenous infusion
50 ml of normal saline intravenous infusion
Locations (1)
Southern medical university Nanfang hospital
Guangzhou, China